Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma

PURPOSE: We examined p16, p21 and p53 expression in combination with the presence of human papillomavirus (HPV) DNA as molecular markers to predict survival in patients with stage IV hypopharyngeal squamous cell carcinoma (HSCC). METHODS: Paraffin-embedded tumours from HSCC patients (n = 75) were ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ernoux-Neufcoeur, Perle, Arafa, Mohammad, Decaestecker, Christine, Duray, Anaëlle, Remmelink, Myriam, Leroy, Xavier, Herfs, Michael, Somja, Joan, Depuydt, Christophe E., Delvenne, Philippe, Saussez, Sven
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015171/
https://www.ncbi.nlm.nih.gov/pubmed/20376678
http://dx.doi.org/10.1007/s00432-010-0871-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015171/
https://www.ncbi.nlm.nih.gov/pubmed/20376678
http://dx.doi.org/10.1007/s00432-010-0871-2

Ejemplares similares